Highlights from the 2015 Geneva Motor Show

Vaccines

A conceptual image of the vaccine patch developed at MIT that could enable the use of DNA ...

Taking a two-month-old in for vaccination shots and watching them get stuck with six needles in rapid succession can be painful for child and parent alike. If the work of an MIT team of researchers pans out, those needles may be thing of the past thanks to a new dissolvable polymer film that allows the vaccination needle to be replaced with a patch. This development will not only make vaccinations less harrowing, but also allow for developing and delivering vaccines for diseases too dangerous for conventional techniques.  Read More

Tobacco plants used in the development of the vaccine

A familiar news topic during the flu season is the difficulties that the authorities face in producing enough flu vaccine fast enough to control the outbreak. That’s a serious enough problem, but when the influenza outbreak turns out to be the start of a global pandemic, then hundreds of millions of lives could be at risk. To combat this, the Defense Advanced Research Projects Agency (DARPA) has developed a new way of making vaccines that has turned out 10 million doses of H1N1 influenza vaccine in a month, in a recent test run.  Read More

Methamphetamine addicts may one day be able to receive a vaccine, that keeps them from get...

Methamphetamine is one of the most addictive and thus commonly-used street drugs – according to the United Nations Office on Drugs and Crime, there are currently nearly 25 million meth addicts worldwide. Help may be on the way, however. Scientists from The Scripps Research Institute have had success in using a methamphetamine vaccine to block the effects on meth on lab rats.  Read More

The spores of the Bacillus subtilis (pictured above) have been implemented into a vaccine ...

Taking the “ouch” out of injections is a worthy endeavor, but what if they could be avoided entirely? New research conducted at Royal Holloway, University of London offers the hope of achieving just this, by using a bacterium to deliver a vaccine which can be administered via nasal spray, oral liquid, capsule, or small soluble film placed under the tongue, thus reducing the risk of spreading infectious diseases like HIV.  Read More

Dr. Marit Kramski (left) and colleagues Behnaz Heydarchi and Rob Center, with bags of froz...

Despite the misgivings that many people have surrounding cow’s milk, it is a good source of nutrients such as calcium and vitamin D. Now, thanks to scientists at Melbourne University, special milk may also be used to protect people from HIV. Working with the Australian biotechnology company Immuron Ltd, a team led by Dr. Marit Kramski has vaccinated pregnant cows with an HIV protein – the first milk that those animals produced after giving birth contained HIV-disabling antibodies.  Read More

A basic diagram of MIT's painless drug delivery system

Although some medications just don’t work when taken orally, the fact is that nobody likes getting injections. Research being conducted at MIT, however, could lead to a new painless method of drug delivery via the skin. Harsh though it might sound, it involves using ultrasound to blast off the outer layer of skin, so that drugs can then get into the bloodstream.  Read More

A beam entrance view of the laser injector (Photo: Jack Yoh/Seoul National University)

Nobody likes getting their shots, but whether childhood immunization, annual flu vaccination, or whatever else, we're required to undergo the uncomfortable sensation of needle piercing skin multiple times throughout our lives. However, a new laser-based system promises to take the “ouch” out of injections by delivering shots as painlessly as being struck by a puff of air.  Read More

A new understanding of the immune system may be paving the way for the development of a va...

Most people probably know that plaque buildup in the arteries surrounding the heart is one of the major causes of heart disease. The reason that the plaque does accumulate, however, is often due to an inflammation of the artery walls. Recently, scientists from California’s La Jolla Institute for Allergy & Immunology were able to identify the type of immune cells responsible for that inflammation. With this knowledge in hand, they now hope to be able to develop a vaccine for heart disease.  Read More

A single dose of a new nicotine vaccine could provide lifetime protection from the pleasur...

Researchers at Weill Cornell Medical College have developed a vaccine that could help existing smokers quit for good and prevent those yet to try cigarettes from ever becoming addicted. The vaccine turns the recipient’s kidney into a factory continuously churning out antibodies that clear the bloodstream of nicotine before it has a chance to reach the brain and deliver it’s addictive rush. Unlike previously tested nicotine vaccines that only last a few weeks, the effects of a single dose of this new vaccine should last a lifetime.  Read More

Electron micrographs of hepatitis C virus purified from cell culture

Although the existence of hepatitis C had been postulated in the 1970s, it wasn’t until 1989 that a team led by Michael Houghton identified the virus. Often being asymptomatic, it is estimated between 130 – 170 million people worldwide are infected with the virus that can lead to scarring of the liver and cirrhosis. Although treatment with medication is available, it isn’t effective in all cases and between 20 to 30 percent of those infected with hepatitis C develop some form of liver disease. Now Houghton and a team at the University of Alberta have developed a vaccine from a single strain that is effective against all known strains of the disease.  Read More

Looking for something? Search our 30,953 articles
Editor's Choice
Product Comparisons